These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30231411)

  • 1. Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness.
    Teoh D; Smith TJ; Song M; Spirtos NM
    Am Soc Clin Oncol Educ Book; 2018 May; 38():469-479. PubMed ID: 30231411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment].
    Istenes I; Nagy Z; Demeter J
    Magy Onkol; 2016 Jun; 60(2):165-75. PubMed ID: 27275643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced peripheral neuropathy: Current status and progress.
    Brewer JR; Morrison G; Dolan ME; Fleming GF
    Gynecol Oncol; 2016 Jan; 140(1):176-83. PubMed ID: 26556766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCCN guidelines for survivorship expanded to address two common conditions.
    Kvale E; Urba SG
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):825-7. PubMed ID: 24853226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN task force report: management of neuropathy in cancer.
    Stubblefield MD; Burstein HJ; Burton AW; Custodio CM; Deng GE; Ho M; Junck L; Morris GS; Paice JA; Tummala S; Von Roenn JH
    J Natl Compr Canc Netw; 2009 Sep; 7 Suppl 5():S1-S26; quiz S27-8. PubMed ID: 19755042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.
    Gutiérrez-Gutiérrez G; Sereno M; Miralles A; Casado-Sáenz E; Gutiérrez-Rivas E
    Clin Transl Oncol; 2010 Feb; 12(2):81-91. PubMed ID: 20156778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced peripheral neuropathy #197.
    Fernandez C; Mehta Z; Espenlaub A; Ellison N
    J Palliat Med; 2014 Aug; 17(8):965-6. PubMed ID: 25026539
    [No Abstract]   [Full Text] [Related]  

  • 9. Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors.
    Chan CW; Cheng H; Au SK; Leung KT; Li YC; Wong KH; Molassiotis A
    Eur J Oncol Nurs; 2018 Oct; 36():135-141. PubMed ID: 30322504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.
    Gilchrist L
    Semin Pediatr Neurol; 2012 Mar; 19(1):9-17. PubMed ID: 22641071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disturbance in ADL from Chemotherapy-induced Peripheral Neuropathy and Quality of Life in Cancer Patients: The Mediating Effect of Psychological Distress].
    Kim KY; Lee SH; Kim JH; Oh PJ
    J Korean Acad Nurs; 2015 Oct; 45(5):661-70. PubMed ID: 26582111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.
    Sexton M; Garcia JM; Jatoi A; Clark CS; Wallace MS
    J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):86-98. PubMed ID: 34850897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis in cancer care.
    Abrams DI; Guzman M
    Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy.
    Donald GK; Tobin I; Stringer J
    Acupunct Med; 2011 Sep; 29(3):230-3. PubMed ID: 21875929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy?
    van Dam DG; Beijers AJ; Vreugdenhil G
    Acta Oncol; 2016 Dec; 55(12):1495-1497. PubMed ID: 27606940
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptoms: Chemotherapy-Induced Peripheral Neuropathy.
    Schneider BP; Hershman DL; Loprinzi C
    Adv Exp Med Biol; 2015; 862():77-87. PubMed ID: 26059930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neurotoxicity: how can we improve knowledge?
    Cavaletti G
    Lancet Oncol; 2009 Jun; 10(6):539-40. PubMed ID: 19482244
    [No Abstract]   [Full Text] [Related]  

  • 18. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mindfulness and bodily distress.
    Fjorback LO
    Dan Med J; 2012 Nov; 59(11):B4547. PubMed ID: 23171754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy.
    Magnowska M; Iżycka N; Kapoła-Czyż J; Romała A; Lorek J; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2018; 89(4):200-4. PubMed ID: 29781075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.